The study highlights that specific patient subgroups derive prognostic benefits from CABG beyond symptomatic improvement.
May support CABG consideration in select subgroups for prognostic benefit; hypothesis-generating and requires randomized confirmation.
There are subgroups of patients who have prognostic benefits of CABG in addition to symptomatic improvement that is well documented with both PCI and CABG.
No takes yet. Share an insight, caveat, or question.
Vaez et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: